AMSTERDAM, June 1, 2016 /PRNewswire/ -- Royal
Philips (NYSE: PHG; AEX: PHIA) today announced new study
results demonstrating the use of a connected medication dispensing
technology can greatly benefit patients with chronic conditions,
helping them better comply with long-term therapy. Over the span of
one year, user data from more than 1,300 patients in the Netherlands was analyzed, showing 96% of
patients using Philips Medido, a connected medication dispensing
solution, were adherent to their medication schedule. Data from the
study also showed that patients using Medido stayed adherent to
long-term therapy over time, showing little or no change in
adherence over the course of the year.
Successful treatment with prescription medication requires
consistent use over time. Studies have shown that during the
treatment of chronic illnesses approximately 50% of patients do not
adhere to their physician's long-term therapy recommendations
[1,2]. While patients rely on their medications to keep them
healthy and help them manage chronic conditions, complex medication
schedules can often lead to mistakes, such as missed doses,
incorrect amounts, or taking medications at the wrong time. Through
a connected medication dispensing solution like Medido, patients
living with chronic conditions can better manage their medication
schedules, resulting in higher medication adherence and reduced
costs of care.
"Proper medication adherence is such a crucial part to managing
a chronic illness, and yet the more complicated a patient's care
plan, the harder it can be to keep track of pills, doses, and the
times they need to take their medication," said Kimberly O'Loughlin, Senior Vice President and
General Manager of Home Monitoring, Philips. "By providing patients
and caregivers with a solution that simplifies this part of the
care process, they're able to feel more independent and secure in
their care, and feel more confident aging in the comfort of their
own homes."
The study looked into 881,000 medication moments of 1,379
patients in the Netherlands who on
average took three doses per day. Key data and findings from the
study include:
- 96% of patients using Medido had a medication adherence rate
over the World Health Organization's (WHO) standard of 80%.
- Patients who required two or more medication doses per day
maintained an adherence rate at around 94% with Medido.
- Medication adherence remained consistent over time, with no
significant differences during the yearlong study.
In addition to improving medication adherence, connected
technology solutions can have a significant economic impact.
Earlier study findings conclude that an estimated costs saving of
up to 40% per patient could be achieved for specific groups of
patients when connected dispensing solutions are part of the
patient's regimen [3].
Philips Medido is an innovative home medication dispensing
service designed to support chronically ill patients and care
providers. When the patient's scheduled medication time arrives,
the dispenser automatically reminds them, ensures that the correct
medication is being released at the correct time and then releases
and opens individual pouches according to the patient's prescribed
regimen. The solution monitors removing medication from the
dispenser and remotely alerts nursing staff when medication is not
taken from the device, helping to streamline the normally
time-consuming task of medication management and allowing them to
focus on additional care issues.
Medido is currently available in the
Netherlands, with additional launches expected in the U.S.
and Europe later this year. For
more than 40 years, Philips has been a leader in connected home
health solutions with its Lifeline business, helping seniors live
more safely and independently. Last year, Philips launched
CareSage, a predictive analytics engine that helps care providers
remotely manage at-risk patients and predicts whether a patient
will need emergency transport in the next 30 days.
Philips will also be showcasing its latest connected health
software, solutions and services at eHealth Week 2016 in
Amsterdam. For more information on
Philips presence at eHealth Week, please visit:
www.philips.nl/ehealthweek.
[1] Sabaté E, et al. Adherence to Long-Term Therapies: Evidence
for Action. Geneva, Switzerland:
World Health Organization 2003.
[2] Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo
Clinic Proceedings 2011; 86 (4): 304-314.
[3] Based on calculations for a patient receiving two combined-care
visits and one medication-assistance-only visit a day in the Dutch
context. This calculation was not part of the adherence data study.
More info can be found in the white paper "Medido, a smart
medication dispensing solution, shows high rates of medication
adherence and potential to reduce cost of care"
http://tinyurl.com/hprpocy
For further information, please contact:
Kathy O'Reilly
Philips Group Communications
(o) 978-659-2638 (mobile) 978-221-8919
Kathy.oreilly@philips.com
Twitter: @kathyoreilly
Joost Maltha
Philips Communications Healthcare Informatics, Solutions and
Services
Tel. +31 6 10 55 8116
E-mail: joost.maltha@philips.com
Twitter: @joostmaltha
About Royal
Philips
Royal Philips
(NYSE: PHG, AEX: PHIA) is a leading health technology company
focused on improving people's health and enabling better outcomes
across the health continuum from healthy living and prevention, to
diagnosis, treatment and home care. Philips leverages advanced
technology and deep clinical and consumer insights to deliver
integrated solutions. The company is a leader in diagnostic
imaging, image-guided therapy, patient monitoring and health
informatics, as well as in consumer health and home care.
Headquartered in the Netherlands,
Philips' health technology portfolio generated 2015 sales of
EUR 16.8 billion and employs
approximately 69,000 employees with sales and services in more than
100 countries. News about Philips can be found at
www.philips.com/newscenter.
Infographic -
http://photos.prnewswire.com/prnh/20160531/373807-INFO
Photo - http://photos.prnewswire.com/prnh/20160531/373805
Logo - http://photos.prnewswire.com/prnh/20140122/NE50581LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/connected-technology-solutions-dramatically-improve-medication-adherence-according-to-new-study-from-philips-300277270.html
SOURCE Royal Philips